Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 357,662,592
  • Shares Outstanding, K 2,655,056
  • Annual Sales, $ 81,581 M
  • Annual Income, $ 15,297 M
  • 60-Month Beta 0.70
  • Price/Sales 4.37
  • Price/Cash Flow 12.32
  • Price/Book 6.05

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 2.42
  • Number of Estimates 7
  • High Estimate 2.51
  • Low Estimate 2.30
  • Prior Year 2.10
  • Growth Rate Est. (year over year) +15.24%

Price Performance

See More
Period Period Low Period High Performance
1-Month
131.75 +0.89%
on 07/16/19
144.98 -8.32%
on 06/25/19
-7.17 (-5.12%)
since 06/14/19
3-Month
128.52 +3.42%
on 05/29/19
144.98 -8.32%
on 06/25/19
-5.10 (-3.70%)
since 04/16/19
52-Week
121.00 +9.85%
on 12/24/18
148.99 -10.79%
on 12/04/18
+8.23 (+6.60%)
since 07/16/18

Most Recent Stories

More News
Markets Right Now: Stock indexes are mixed in midday trade

NEW YORK (AP) — The latest on developments in financial markets (all times local):

JPM : 114.36 (+0.40%)
JNJ : 132.98 (-1.28%)
US stocks flatten as earnings reports ramp up

NEW YORK (AP) — U.S. stocks flattened in morning trading as investors assessed a mixed bag of corporate earnings and economic reports.

JNJ : 132.98 (-1.28%)
TXN : 117.98 (-1.55%)
AbbVie (ABBV) Acquires Mavupharma to Boost Cancer Portfolio

AbbVie (ABBV) buys Mavupharma to develop novel treatments for cancer using the latter's STING signaling pathway.

JNJ : 132.98 (-1.28%)
ABBV : 69.37 (-1.28%)
RHHBY : 33.6300 (+0.24%)
ADRO : 1.50 (-1.32%)
Johnson & Johnson 2Q profit jumps 42% despite lower sales

Johnson & Johnson posted slightly lower sales across much of its business in the second quarter, but a big one-time gain and lower spending on marketing and administration boosted its profit a whopping...

JNJ : 132.98 (-1.28%)
Better-Than Expected Retail Sales in June

Better-Than Expected Retail Sales in June

WFC : 45.41 (-2.78%)
JPM : 114.36 (+0.40%)
JNJ : 132.98 (-1.28%)
GS : 213.74 (+1.02%)
J&J (JNJ) Beats on Q2 Earnings, Ups 2019 Sales Growth View

J&J (JNJ) beats estimates for both earnings and sales in the second quarter of 2019 and raises 2019 guidance for operational sales growth for the second time this year.

MRK : 81.18 (+0.27%)
JNJ : 132.98 (-1.28%)
ABBV : 69.37 (-1.28%)
TEVA : 8.41 (-1.75%)
Global shares edge up on upbeat US earnings reports

TOKYO (AP) — Global stock markets were mostly higher on Tuesday after several major U.S. companies reported quarterly earnings that were better than expected.

WFC : 45.41 (-2.78%)
JNJ : 132.98 (-1.28%)
GS : 213.74 (+1.02%)
Delaware Innovation Space Launches an Entrepreneurial Advisory Council

The Delaware Innovation Space is proud to announce the formation of the Entrepreneurial Advisory Council (the EAC) for the Delaware Innovation Space and is pleased to introduce its foundational class which...

JNJ : 132.98 (-1.28%)
Johnson & Johnson (JNJ) Tops Q2 Earnings and Revenue Estimates

Johnson & Johnson (JNJ) delivered earnings and revenue surprises of 6.61% and 1.17%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

JNJ : 132.98 (-1.28%)
Johnson & Johnson Reports 2019 Second-Quarter Results

Johnson & Johnson (NYSE: JNJ) today announced results for second-quarter 2019. "We delivered solid second-quarter underlying sales growth and strong earnings growth that enables us to make investments...

JNJ : 132.98 (-1.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade JNJ with:

Business Summary

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin...

See More

Key Turning Points

2nd Resistance Point 137.08
1st Resistance Point 135.90
Last Price 132.98
1st Support Level 133.99
2nd Support Level 133.26

See More

52-Week High 148.99
Fibonacci 61.8% 138.30
Fibonacci 50% 134.99
Last Price 132.98
Fibonacci 38.2% 131.69
52-Week Low 121.00

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar